6.
Gagliardi D, Dziembowski A
. 5' and 3' modifications controlling RNA degradation: from safeguards to executioners. Philos Trans R Soc Lond B Biol Sci. 2018; 373(1762).
PMC: 6232590.
DOI: 10.1098/rstb.2018.0160.
View
7.
Lee Y, Choe J, Park O, Kim Y
. Molecular Mechanisms Driving mRNA Degradation by mA Modification. Trends Genet. 2020; 36(3):177-188.
DOI: 10.1016/j.tig.2019.12.007.
View
8.
Galton R, Fejes-Toth K, Bronner M
. Co-option of the piRNA pathway to regulate neural crest specification. Sci Adv. 2022; 8(32):eabn1441.
PMC: 9365273.
DOI: 10.1126/sciadv.abn1441.
View
9.
Cong L, Zhao Q, Sun H, Zhou Z, Hu Y, Li C
. A novel long non-coding RNA SLNCR1 promotes proliferation, migration, and invasion of melanoma via transcriptionally regulating SOX5. Cell Death Discov. 2024; 10(1):160.
PMC: 10984963.
DOI: 10.1038/s41420-024-01922-7.
View
10.
Delhermite J, Tafforeau L, Sharma S, Marchand V, Wacheul L, Lattuca R
. Systematic mapping of rRNA 2'-O methylation during frog development and involvement of the methyltransferase Fibrillarin in eye and craniofacial development in Xenopus laevis. PLoS Genet. 2022; 18(1):e1010012.
PMC: 8797249.
DOI: 10.1371/journal.pgen.1010012.
View
11.
Oh J, Kim C, Jeong D, Kim Y, Kim M, Cho J
. The homeoprotein HOXB2 limits triple-negative breast carcinogenesis via extracellular matrix remodeling. Int J Biol Sci. 2024; 20(3):1045-1063.
PMC: 10845296.
DOI: 10.7150/ijbs.88837.
View
12.
Leathers T, Rogers C
. Time to go: neural crest cell epithelial-to-mesenchymal transition. Development. 2022; 149(15).
PMC: 9440755.
DOI: 10.1242/dev.200712.
View
13.
Guo S, Huang J, Li G, Chen W, Li Z, Lei J
. The role of extracellular vesicles in circulating tumor cell-mediated distant metastasis. Mol Cancer. 2023; 22(1):193.
PMC: 10688140.
DOI: 10.1186/s12943-023-01909-5.
View
14.
Jasinski-Bergner S, Blumke J, Wickenhauser C, Seliger B
. Relevance of 2'-O-Methylation and Pseudouridylation for the Malignant Melanoma. Cancers (Basel). 2021; 13(5).
PMC: 7963185.
DOI: 10.3390/cancers13051167.
View
15.
Sanchez-Tillo E, Lazaro A, Torrent R, Cuatrecasas M, Vaquero E, Castells A
. ZEB1 represses E-cadherin and induces an EMT by recruiting the SWI/SNF chromatin-remodeling protein BRG1. Oncogene. 2010; 29(24):3490-500.
DOI: 10.1038/onc.2010.102.
View
16.
Samuels M, Jones W, Towler B, Turner C, Robinson S, Giamas G
. The role of non-coding RNAs in extracellular vesicles in breast cancer and their diagnostic implications. Oncogene. 2023; 42(41):3017-3034.
PMC: 10555829.
DOI: 10.1038/s41388-023-02827-y.
View
17.
Moore M
. From birth to death: the complex lives of eukaryotic mRNAs. Science. 2005; 309(5740):1514-8.
DOI: 10.1126/science.1111443.
View
18.
Mansoori B, Terp M, Mohammadi A, Pedersen C, Ditzel H, Baradaran B
. HMGA2 Supports Cancer Hallmarks in Triple-Negative Breast Cancer. Cancers (Basel). 2021; 13(20).
PMC: 8533747.
DOI: 10.3390/cancers13205197.
View
19.
Huang Z, Luo C, Hou X, Yu D, Su Y, Li X
. The mA methyltransferase METTL3 affects cell proliferation and migration by regulating YAP expression in Hirschsprung disease. Pediatr Surg Int. 2023; 39(1):126.
DOI: 10.1007/s00383-023-05421-1.
View
20.
Deng X, Liu Z, Wang B, Ma J, Meng X
. The DDX6/KIFC1 signaling axis, as regulated by YY1, contributes to the malignant behavior of pancreatic cancer. FASEB J. 2024; 38(7):e23581.
DOI: 10.1096/fj.202400166R.
View